New antimicrobial agents approved by the U.S. Food and Drug Administration from 2007 to 2009 and new indications for previously approved agents - PubMed (original) (raw)
New antimicrobial agents approved by the U.S. Food and Drug Administration from 2007 to 2009 and new indications for previously approved agents
No authors listed. Antimicrob Agents Chemother. 2010 Sep.
No abstract available
Similar articles
- New antimicrobial agents approved by the U.S. Food and Drug Administration in 2010 and 2011 and new indications for previously approved agents(a).
[No authors listed] [No authors listed] Antimicrob Agents Chemother. 2011 Nov;55(11):5412. doi: 10.1128/AAC.05564-11. Antimicrob Agents Chemother. 2011. PMID: 22002960 Free PMC article. No abstract available. - New antimicrobial agents approved by the U.S. Food and Drug Administration in 2006 and new indications for previously approved agents.
[No authors listed] [No authors listed] Antimicrob Agents Chemother. 2007 Jul;51(7):2649. doi: 10.1128/AAC.00580-07. Antimicrob Agents Chemother. 2007. PMID: 17684007 Free PMC article. No abstract available. - New antimicrobial agents approved by the U.S. Food and Drug Administration in 2005 and new indications for previously approved agents.
[No authors listed] [No authors listed] Antimicrob Agents Chemother. 2006 May;50(5):1912. doi: 10.1128/AAC.50.5.1912.2006. Antimicrob Agents Chemother. 2006. PMID: 16641478 Free PMC article. No abstract available. - Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984-2018: an evaluation of Food and Drug Administration flexibilities.
Darrow JJ, Najafzadeh M, Stefanini K, Kesselheim AS. Darrow JJ, et al. Lancet Infect Dis. 2020 Jul;20(7):e159-e164. doi: 10.1016/S1473-3099(20)30197-3. Epub 2020 Jun 2. Lancet Infect Dis. 2020. PMID: 32502431 Review. - New drugs and drug products approved in 1997.
Gage TW. Gage TW. Tex Dent J. 1998 Sep;115(9):51-60. Tex Dent J. 1998. PMID: 9807157 Review. No abstract available.
Cited by
- Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens.
Jabés D, Brunati C, Candiani G, Riva S, Romanó G, Donadio S. Jabés D, et al. Antimicrob Agents Chemother. 2011 Apr;55(4):1671-6. doi: 10.1128/AAC.01288-10. Epub 2011 Jan 10. Antimicrob Agents Chemother. 2011. PMID: 21220527 Free PMC article. - Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity.
Bionda N, Stawikowski M, Stawikowska R, Cudic M, López-Vallejo F, Treitl D, Medina-Franco J, Cudic P. Bionda N, et al. ChemMedChem. 2012 May;7(5):871-82. doi: 10.1002/cmdc.201200016. Epub 2012 Mar 5. ChemMedChem. 2012. PMID: 22392790 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources